Learn More
PURPOSE We sought to compare three doxorubicin-based therapies for metastatic breast cancer for response frequency, time to treatment failure (TTF), and survival. MATERIALS AND METHODS Women with(More)
559 Background: Recent data show older pts derive the same relapse-free and survival benefits as younger pts when treated with newer more intense adjuvant ADJ Cx regimens (Jama 293:1073, 2005). We(More)